DZS Clinical Services Acquired by WDB Holdings Co., Ltd., to Strengthen CRO Business

Bound Brook, N.J., Sept. 6, 2018 (Business Wire) — DZS Clinical Services, which provides clinical development and data analytic services for global pharmaceutical, biotech and medical device companies, today announced that it has been acquired by WDB Medical Data, Inc., (WDBMD), a U.S. subsidiary of WDB Holdings Co., Ltd. WDBMD is a global provider of […]

WDB Holdings Co., Ltd. To Acquire DZS Clinical Services

FOR IMMEDIATE RELEASE WDB Holdings Co., Ltd. Tokyo Stock Exchange code: 2475 Contact: Miki Otsuka Senior Managing Director +81-79-287-0111 Released on August 31, 2018, in Hyogo, Japan Announcement on Acquisition of 100% shares by a subsidiary in the US WDB Holdings Co., Ltd. announces that the Board of the Directors Meeting held on August 31st, 2018 resolved […]

WDB Holdings Co., Ltd. to Acquire DZS Software Solutions, Inc.

FOR IMMEDIATE RELEASE WDB Holdings Co., Ltd. Tokyo Stock Exchange code: 2475 Contact: Miki Otsuka Senior Managing Director +81-79-287-0111 Released on August 31, 2018, in Hyogo, Japan Announcement on Acquisition of 100% shares by a subsidiary in the US WDB Holdings Co., Ltd. announces that the Board of the Directors Meeting held on August 31st, 2018 […]

DZS Clinical Services to Launch Upgraded ClinPlus® 3.1 eClinical Software at Drug Information Association Annual Meeting

(Bound Brook, N.J.; June 14, 2016) — DZS Clinical Services, a global provider of clinical development and data analytic services, has announced that it will be launching its enhanced ClinPlus® 3.1eClinical software at the Drug Information Association Annual Meeting (DIA) in Philadelphia. The ClinPlus eClinical Platform combines electronic data capture, a clinical trial management system, […]

DZS Clinical Services Expands Leadership Team and Operations in the Middle East

(Bound Brook, N.J.; Dec. 15, 2015) — DZS Clinical Services, a global provider of clinical development and data analytic services, has selected George Harb, M.D., as its new vice president of clinical and medical affairs. The addition of Harb to the leadership team will augment DZS’ clinical development management and protocol design capabilities, as well […]

DZS Completes First Bahrain Industry Study; Expands Middle East Services

DZS was contracted over two years ago by SBI Pharmaceuticals to assist in the first Industry Sponsored study in Bahrain; a small island country in the Middle East. DZS provided project management, local monitoring, and biometrics support. The study evaluated 5-ALA and the effect on Bahraini patients with Type II Diabetes and was recently completed. […]